Showing results (461-470 of 1,286) with videos related to
Sort By:
Pageof 129
Journal of Cardiovascular Pharmacology and Therapeutics|January 29, 2005
Case report: aortic dissection and cystic medial degeneration in a 24-year-old without Marfan syndromeChris Caraang, Adel El-BialyJournal of Cardiovascular Pharmacology and Therapeutics|April 12, 2005
Effect of flaxseed consumption on blood pressure, serum lipids, hemopoietic system and liver and kidney enzymes in healthy humansCarlo Stuglin, Kailash PrasadJournal of Cardiovascular Pharmacology and Therapeutics|April 12, 2005
Long-term benefits and limitations of combined antianginal drug therapy in elderly patients with symptomatic chronic coronary artery diseasePiero O Bonetti, Christoph Kaiser, Michael J Zellweger, et al.Journal of Cardiovascular Pharmacology and Therapeutics|January 4, 2008
Role of oxidants and antioxidants in atherosclerosis: results of in vitro and in vivo investigationsRüdiger Siekmeier, Christian Steffen, Winfried MärzJournal of Cardiovascular Pharmacology and Therapeutics|February 22, 2008
The first year post-heart transplantation: use of immunosuppressive drugs and early complicationsNasir Z Sulemanjee, Ramanna Merla, Scott D Lick, et al.Journal of Cardiovascular Pharmacology and Therapeutics|February 22, 2008
Cyclooxygenase-2 inhibitors and most traditional nonsteroidal anti-inflammatory drugs cause similar moderately increased risks of cardiovascular diseaseCharles H Hennekens, Steven BorzakJournal of Cardiovascular Pharmacology and Therapeutics|February 22, 2008
Cardiac oxidative stress is elevated at the onset of dilated cardiomyopathy in streptozotocin-diabetic ratsMaría J Crespo, Joaquin Zalacaín, Donald C Dunbar, et al.Journal of Cardiovascular Pharmacology and Therapeutics|April 17, 2008
Intracoronary abciximab use in patients undergoing PCI at a community hospital: a single operator experienceSandeep S Patel, Hiralal Rana, Daniel A N MascarenhasJournal of Cardiovascular Pharmacology and Therapeutics|May 23, 2008
Pharmacoeconomic concepts in antiplatelet therapy: understanding cost-effectiveness analyses using clopidogrel as an exampleWilliam S WeintraubJournal of Cardiovascular Pharmacology and Therapeutics|January 22, 2025
Vitamin K Antagonist Use and Level of Anticoagulation Control Among Patients at a Tertiary Hospital in Northern TanzaniaSarah K Gharib, Abid M Sadiq, Faryal M Raza, et al.Pageof 129